ZYMED CLINICAL SOLUTIONS LIMITEDActive

Company number 07980546Private limited companyIncorporated 2012

Key figures

£78,424+24.3%
Net assets 2024/25
+13.4%
Average annual growth 2019/20–2024/25
020 k40 k60 k80 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, ZYMED CLINICAL SOLUTIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets53,99255,76363,80070,79088,221
Total liabilities12,7097,7528,0007,6829,797
Net assets / total equity41,28348,01155,80063,10878,424
Average number of employees55555

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ZYMED CLINICAL SOLUTIONS LIMITED

Company

ZYMED CLINICAL SOLUTIONS LIMITED is a private limited company registered with Companies House under company number 07980546. It was incorporated on 7 Mar 2012. Its status is active. The registered office is in London (EC2A). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £78,424, up 24.3% on the previous year. Total assets were £88,221 and total liabilities £9,797. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 21 Mar 2027.